©2025 RXinsider | RXinsider Market Intelligence Group | 2025
©2025 RXinsider | RXinsider Market Intelligence Group | 2025
75%
of approximately 7,000 new
drug development were
represented by specialty
drugs in 2024.
55%
of total pharmacy spending
in 2024 was accounted for
specialty medications.
3,200
Specialty pharmacies in the U.S.
as of December 2024 (approx.).
3,000
Individual members, including pharmacists
represented by NASP.
55%
of net spending was accounted
from specialty medications
in March 2022.
SPECIALTY
PRACTICE
SETTING
SNAPSHOT
50
novel drugs approved in 2024 by the
FDA’s Center for Drug Evaluation and
Research (CDER).
Asembia founded one of the leading group purchasing
organizations (GPOs) in 2005.
Source: De�nitive Healthcare
Source: NASP
Source: IQVIA
Source: NASP
Source: IQVIA
Source: FDA
Source: Asembia
52%
of total drug spending is from specialty
pharmacy spending, up from 40% in 2020.
Source: IQVIA